PAREXEL Advances Patient-Centric Drug Development with Introduction of its Patient Innovation Center


BOSTON, September 11, 2018 – PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced the launch of its Patient Innovation Center, designed to help guide sponsors in their efforts to improve efficiency and success across all areas of biopharmaceutical development including clinical trial design, recruitment, execution and market access. With a patient-centric approach, the Center can help sponsors improve the drug development process by reducing the practical, financial and geographical barriers patients and caregivers often face, and optimize patient involvement and engagement.

Simplifying the patient journey with a focus on the patient’s needs and experience has been proven to enhance the drug development and commercialization process. A report recently released by The Economist Intelligence Unit (EIU) and commissioned by PAREXEL found that patient-centric trials took almost half the time to recruit participants and that drugs developed using these approaches were 19 percent more likely to be launched. However, patient-centric designs were only utilized in 5.2 percent of Phase II and III trials across the industry. In the commercialization phase, a patient-centric approach can enhance the process as well. With the Patient Innovation Center, PAREXEL will help facilitate sponsors’ ability to develop comprehensive strategies for patient-centric drug development and commercialization and leverage new approaches including Patient-Centric Protocol Optimization, virtual (or at-home) trials and direct-with-patient studies.

“While the evidence is clear that patient-centric approaches can improve the development process, many sponsors remain in need of a roadmap to effectively apply these strategies over time,” said Sy Pretorius, M.D., Senior Vice President, Medical & Scientific Services, PAREXEL. “At PAREXEL we are committed to designing trials with patients in mind. Through the Patient Innovation Center, we aim to bring the full breadth of our services, expertise and innovation to clients to help more-effectively implement these approaches, reducing the barriers and optimizing patient involvement throughout the drug development and commercialization journey.”

PAREXEL’s Patient Innovation Center services include:

  • Study Planning: PAREXEL’s Patient-Centric Protocol Optimization service proactively involves patients and PAREXEL Site Alliance expert nurses in the protocol-design process to identify and address potential practical challenges to study participation. By maintaining focus on patients’ needs and augmenting the feasibility process, patient burden can be reduced and the experience for participants optimized. By using a combination of web listening, patient, caregiver and site staff input, PAREXEL can help sponsors positively impact study recruitment and retention.
  • Study Implementation: PAREXEL’s patient-centric focus can help ensure a pragmatic approach to study implementation to reduce patient burden, including the deployment of virtual trials. It includes elements such as online recruitment, eConsent, home nursing, direct-to-patient drug shipments, patient apps and video dosing to enhance patient experience and compliance. PAREXEL’s Patient Sensor Solution service is focused on continuous data collection through the use of wearables to remotely capture, transmit and store data in a secure platform powered by PAREXEL’s Perceptive® Cloud. Deployment of the virtual trials service brings the research to patients and their caregivers, reducing the practical, financial and geographical barriers to clinical study participation for patients and their families.
  • Patient & Market Access: PAREXEL’s commitment to encompassing the patient’s needs and experience extends throughout the product development lifecycle – and is critically focused on ensuring patient access to important therapies. In preparing for and supporting product commercialization, PAREXEL aims to deliver research that reflects patients’ true care path and experience – and that will ultimately support the key clinician, payer, and regulatory decisions that will drive patient access. PAREXEL’s approach leverages technologies and processes to collect patient-specific data via mobile sensors and applications, patient-reported outcomes surveys, direct-to-patient studies and other strategies – all informed by a deep understanding of the patient care path, and the market’s clinical and payer evidence requirements.

“In today’s drug development landscape, it is more important than ever that we as an industry place the patient’s needs at the core of everything we do,” said Peyton Howell, Chief Commercial and Strategy Officer, PAREXEL. “At PAREXEL, we understand how critical patient involvement and engagement are to successful clinical development and, ultimately, access to therapies. As we look to the future, we will continue to seek new ways to optimize the patient experience as we partner with our clients to develop and deliver important new medicines.”

For more information about PAREXEL visit www.parexel.com/patientinnovation.

About PAREXEL International
PAREXEL International Corporation is a leading innovator of global biopharmaceutical services. We simplify our clients’ journey of transforming scientific discoveries into new medical treatments for patients with high-quality Phase I-IV clinical research, regulatory, consulting and market access services. PAREXEL develops breakthrough innovations and solutions by leveraging its comprehensive therapeutic, technical and functional expertise, in more than 100 countries around the world. For more information, visit www.PAREXEL.com.

PAREXEL is a registered trademark of PAREXEL International Corporation. All other trademarks are the property of their respective owners.

# # #

PAREXEL Contacts:
Media:
Wendy Ryan
Tel.: +1 781-434-5104
Email: Wendy.Ryan@PAREXEL.com

Kathryn McMahon Arrigg, PAN Communications
Tel.: +1 617-502-4300
Email: PAREXEL@pancomm.com

Have any Question or Comment?

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

::::::::::::::::::::::::::::::::::6733:::::::::::::::::::::::::::::::::;;

:::::::::::::::::::::::::::::925:::::::::::::::::::::::::::::::

TRIO STEEL IS ONE OF THE MOST TRUSTED BRAND AND LEADING EXPORTER AND SUPPLIER OF CARBON STEEL, ALLOY STEEL & STAINLESS STEEL PIPES & PIPE FITTINGS MATERIAL. Triosteel is one of the leading Suppliers and Exporters of API 5L Pipe in Singapore. Triosteel also Exports to many countries like Indonesia, Iran, Saudi Arabia & many more. An API 5L pipe is manufactured by adhering to the specifications laid down by the International Organization for Standardization (ISO) 3183.

2780

buy! buy! CHEAP! Telefonie VoIP CHEAP! buy! buy! CHEAP!

2781

buy! buy! CHEAP! Telefonie VoIP CHEAP! buy! buy! CHEAP!

——————————————–

For the 2012 MLB period, we found an totals forecast Joao’s Renowned Over/Under João Zorro Gonçalves, Zcode Totals Pro, System of the time with progressions that have been successful over 98 98% ... We eventually perfected our over/under program ( Zcodesystemexclusive ), although it h-AS has brought years of investigation. Five Steps to Making a Winning MLB Method: 1. Execute appropriate cash management tools. 2. MLB rules that are comprehend. 3.Extensive testing back to make sure successful longterm results ...

——————————————–

There is always a challenge when you're dealing with the Foreign Exchange Market. That's just the nature of the beast. The best thing you can do is to learn about how the market operates as a whole so that you will be ready to meet these challenges. iq option penipu Never be misled by any profit gains in binary options. This is the number-one way traders end up losing their money and ultimately failing. Remember that the same things that make you laugh can make you cry in this market, and you can lose that $700.

——————————————–

Learning Polish has never been this fun and easy as with our podcasts Learn Polish with Polishpod101 Start today and become conversational in Polish in no time

——————————————–

The Best Website Agen Poker Resmi www.sakupoker.com Terpercaya come join

——————————————–

Do you need edmonton phone systems service ? Call complete communications today!

——————————————–

High-tech solutions for easy start-up of your IPTV/OTT-business

——————————————–

——————————————–

If you want to purchase not only one item, you have a chance to enjoy privileges. There is a sale’ tab on the site which offers a fantastic range of reduced counterfeit watches and accessories, such as sunglasses, cufflinks, watch straps and pens. Luxury Jewelry Replica At MCA.MN On Sale You get a 5% discount if you buy two pieces, this discount increases to 10% if you buy 4 pieces or more. There is free international shipping on all orders on this site. We also offer customers a free return anytime with a 100% money back guarantee.

——————————————–